HAILEY AGUIAR: Open Payments
NPI 1013402767 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 21 payments from 11 companies in 2025. Trend: 2023 $187 · 2024 $400 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $114 |
| Merck Sharp & Dohme LLC | 4 | $102 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| AstraZeneca Pharmaceuticals LP | 2 | $61 |
| Incyte Corporation | 2 | $44 |
| ARRAY BIOPHARMA INC | 1 | $30 |
| Blueprint Medicines Corporation | 1 | $29 |
| Janssen Biotech, Inc. | 1 | $26 |
| Geron Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
Products named: ENHERTU, Fabhalta, KEYTRUDA, DATROWAY, JAKAFI, LYNPARZA, XALKORI, AYVAKIT.
Industry payments across FL — which companies pay providers there.
